Q2 2023 Holdings
Filed 2023-08-14 | 18 holdings | $152.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $30.3M | 1,152,525 | 19.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $28.2M | 2,181,377 | 18.5% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $27.5M | 2,670,472 | 18.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $13.2M | 1,205,050 | 8.6% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $13.1M | 5,224,600 | 8.6% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $11.5M | 969,374 | 7.5% |
| Pardes Biosciences Inc | COM | 69945Q105 | $7.1M | 3,902,434 | 4.6% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $7.1M | 757,009 | 4.6% |
| Kinnate Biopharma Inc | COM | 49705R105 | $6.2M | 2,048,736 | 4.1% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $2.6M | 3,094,554 | 1.7% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $1.6M | 9,775,849 | 1.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $1.2M | 115,063 | 0.8% |
| Passage BIO Inc | COM | 702712100 | $1.1M | 1,167,343 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $956.1K | 23,000 | 0.6% |
| Athira Pharma Inc | COM | 04746L104 | $571.0K | 193,573 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $321.3K | 21,225 | 0.2% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $166.5K | 20,114 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $34.7K | 18,265 | 0.0% |